A Guidant Corp. implantable heart device may fail about 10 times more often than the company projected
last year, according to a US Food and Drug Administration analysis released in a Texas lawsuit.
The confidential FDA document, written on June 16, 2005, was unsealed in a product liability lawsuit involving
Guidant's defibrillators, $30,000 devices that restart hearts with electrical impulses. |